Skip to content

Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06891196
Enrollment
500
Registered
2025-03-24
Start date
2025-01-15
Completion date
2027-01-15
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis of Hip, Hip Dysplasia, Legg-Calvâe-Perthes Disease

Brief summary

This study, titled "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," aims to assess the long-term effectiveness of treatments for pediatric hip conditions, including hip dysplasia, Legg-Calve-Perthes disease, SCFE, and avascular necrosis.

Detailed description

Conducted at Mayo Clinic, the study combines retrospective chart reviews and prospective follow-up to gather data on clinical outcomes, radiographic measures, and patient-reported outcomes (PROs) like functional status, pain, and quality of life. The retrospective component analyzes records from 1975 to 2024, while the prospective component includes follow-up surveys using validated PRO measures (e.g., HOOS, SF-12, VAS). This study seeks to identify recurrence rates and complications associated with hip treatments, providing insights to improve future care standards for pediatric hip conditions. Data will be securely stored, with confidentiality maintained throughout.

Interventions

OTHERLong-term Follow-up Surveys

Patients will be given surveys, including validated PRO measures such as the Hip Disability and Osteoarthritis Outcomes Score (HOOS), Short-Form 12 (SF-12), Visual Analog Scale (VAS) for pain, and Marx activity scores.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024 * Patients over 18 who can be contacted for follow-up and are willing to participate.

Exclusion criteria

* Patients presenting over age 18 for hip dysplasia * Patients who are unwilling to complete follow up surveys.

Design outcomes

Primary

MeasureTime frameDescription
Revision surgery2 yearsTotal number of patients who required revision surgery for pediatric hip conditions

Secondary

MeasureTime frameDescription
Change in neck-shaft angle measurementBaseline, 2 yearsRadiographic measurement of the neck-shaft angle
Change in acetabular indexBaseline, 2 yearsRadiographic measurement of the acetabular index
Change in migration indexBaseline, 2 yearsRadiographic measurement of the migration index

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREmmanouil Grigoriou, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026